Rachel Nania

AARP Hearing Center Health officials have expanded access to a libido-boosting pill for women, approving its use beyond menopause. Flibanserin, sold as Addyi and first cleared by the U.S. Food and Drug Administration (FDA) in 2015 for premenopausal women,... See more

AARP Hearing Center Health regulators have approved the first pill form of the blockbuster drug Wegovy, providing patients with a new option for weight loss and management that eliminates the need for regular injections. The once-daily Wegovy pill is the ... See more

AARP Hearing Center Millions of Americans who buy their own health insurance are bracing for steep price hikes in the new year. Monthly costs for marketplace plans are expected to more than double on average due to rising premiums and expiring tax credits... See more

AARP Hearing Center Betty Kellenberger’s fascination with the Appalachian Trail began in elementary school, when she first read about the 14-state footpath in Weekly Reader magazine. Decades later, that childhood spark still burns: At 80, Kellenberger rec... See more

AARP Hearing Center The U.S. Food and Drug Administration is warning people with certain glucose monitor sensors to stop using them, after manufacturer Abbott Diabetes Care discovered that they provide incorrect low glucose readings. The devices have been... See more